Mirati Therapeutics
MRTX
$58.70
Share price
0.00%
Change (1 day)
29.75%
Change (1 year)
Categories
Mirati Therapeutics (MRTX) - P/B ratio
P/B ratio as of May 2024 : 4.35
According to Mirati Therapeutics's latest financial reports the company has a price-to-book ratio of 4.35.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Mirati Therapeutics - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.35 | 66.3% |
| 2022-12-31 | 2.62 | -54.88% |
| 2021-12-31 | 5.80 | -28.5% |
| 2020-12-31 | 8.12 | -39.07% |
| 2019-12-31 | 13.3 | 94.52% |
| 2018-12-31 | 6.85 | 90.38% |
| 2017-12-31 | 3.60 | 83.6% |
| 2016-12-31 | 1.96 | -62.01% |
| 2015-12-31 | 5.16 | -42.41% |
| 2014-12-31 | 8.95 | 3.64% |
| 2013-12-31 | 8.64 | |
| 2012-12-31 | N/A | -100% |
| 2011-12-31 | 2.50 | 79.45% |
| 2010-12-31 | 1.39 | 50.27% |
| 2009-12-31 | 0.9276 | |
| 2008-12-31 | N/A | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 TravelCenters of America TA | 1.50 | -65.63% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | -6.34 | -245.83% | Bahamas |